Sarcopenia in pancreatic cancer:Effect on patient outcomes

作     者：Moon Hyung Choi Seung Bae Yoon 

作者机构：Department of RadiologyEunpyeong St.Mary’s HospitalCollege of MedicineThe Catholic University of KoreaSeoul 03312South Korea Division of GastroenterologyDepartment of Internal MedicineCollege of MedicineThe Catholic University of KoreaSeoul 03312South Korea 

出 版 物：《World Journal of Gastrointestinal Oncology》 (世界胃肠肿瘤学杂志（英文版）（电子版）)

年 卷 期：2022年第14卷第12期

页      面：2302-2312页

核心收录：

学科分类：1002[医学-临床医学] 100210[医学-外科学(含：普外、骨外、泌尿外、胸心外、神外、整形、烧伤、野战外)] 100214[医学-肿瘤学] 10[医学] 

基　　金：the National Research Foundation of Korea No.NRF-2021 R1F1A1062255 

主　　题：Sarcopenia Pancreatic cancer Skeletal muscle Computed tomography Outcomes Survival 

摘      要：Pancreatic cancer is a challenging disease with an increasing incidence and extremely poor *** clinical outcomes of pancreatic cancer depend on tumor biology,responses to treatments,and malnutrition or *** represents a severe catabolic condition defined by the age-related loss of muscle mass and strength and affects as much as 70%of malnourished pancreatic cancer *** lumbar skeletal muscle index,defined as the total abdominal muscle area at the L3 vertebral level adjusted by the square of the height,is widely used for assessing sarcopenia in patients with pancreatic *** studies have suggested that sarcopenia may be a risk factor for perioperative complications and decreased recurrence-free or overall survival in patients with pancreatic cancer undergoing *** could also intensify chemotherapyinduced toxicities and worsen the quality of life and survival in the neoadjuvant or palliative chemotherapy ***,not only at the time of diagnosis but also during treatment,decreases survival in patients with pancreatic ***,multimodal interventions may improve sarcopenia and clinical outcomes;however,no study has reported positive *** prospective studies are needed to confirm the prognostic role of sarcopenia and the effects of multimodal interventions in patients with pancreatic cancer.